Search Within

David Augustus Qualls

Formats
  1. Meeting Abstract (7)
  2. Journal Article (5)
  3. Research Letter (3)
  4. Editorial (2)
  5. Review (2)
  6. Conference Paper (1)
Groups
  1. GME, Medicine (20)
  2. Graduate Medical Education (20)
  3. Hematology-Oncology Fellows (20)
  4. Department of Medicine (18)
  5. Hematologic Malignancies, Division of (18)
  6. Center for Hematologic Malignancies (15)

More Groups

People
  1. Gilles Salles (12)
  2. Ahmet Dogan (7)
  3. Anita Kumar (7)
  4. Connie Batlevi (7)
  5. Michelle Okwali (7)
  6. Venkatraman Seshan (6)

More People

Years
  1. 2023 (10)
  2. 2022 (8)
  3. 2021 (2)
Publications
  1. Blood (7)
  2. Blood Advances (3)
  3. Hematological Oncology (2)
  4. Leukemia and Lymphoma (2)
  5. British Journal of Haematology (1)
  6. Cancer Cell (1)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. Taylor & Francis Group (3)
  3. Wiley Blackwell (2)
  4. Biomed Central Ltd (1)
  5. Cell Press (1)
  6. Elsevier Inc. (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of sequential CD19-directed therapies in relapsed and refractory large B cell lymphoma
    Meeting Abstract

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M. H.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G.; Romancik, J. T.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
    Research Letter

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G. T.; Romancik, J.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Retrospective characterization of nodal marginal zone lymphoma
    Journal Article

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Dogan, A.; Epstein-Peterson, Z. D.; Falchi, L.; Hamlin, P. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • A road map for navigating CAR T hematotoxicity
    Editorial

    Qualls, D.; Jacobson, C.
    Blood (2023)

    Fulltext@MSK | Save
  • Comorbidities in DLBCL: Too "Severe4" CAR-T therapy?
    Editorial

    Qualls, D.; Jacobson, C. A.
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Enhancing T‐cell responses to GCB‐like lymphomas with immune‐checkpoint‐blockade‐based therapies
    Meeting Abstract

    Serganova, I.; Bucktrout, R.; Isshiki, Y.; Sarapulov, A.; Santella, A.; Rodriguez, M.; Chakraborty, S.; Brunschvig, S.; Qualls, D.; Vardhana, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: An open label phase II study
    Research Letter

    Qualls, D.; Noy, A.; Straus, D.; Matasar, M.; Moskowitz, C.; Seshan, V.; Dogan, A.; Salles, G.; Younes, A.; Zelenetz, A. D.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Personalized approaches for treatment-naïve mantle cell lymphoma
    Review

    Qualls, D.; Kumar, A.
    Expert Review of Hematology (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era
    Research Letter

    Qualls, D.; Imber, B. S.; Okwali, M.; Hamlin, P. A.; Kumar, A.; Lahoud, O. B.; Matasar, M. J.; Noy, A.; Owens, C.; Zelenetz, A. D.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save